$586 Million is the total value of First Light Asset Management, LLC's 64 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 39.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRMD | Buy | REPRO-MED SYSTEMS INC | $54,289,000 | +15.2% | 7,238,592 | +0.3% | 9.27% | +53.8% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $37,503,000 | -44.6% | 4,050,040 | -0.8% | 6.40% | -26.1% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $36,680,000 | +67.2% | 4,489,553 | +145.8% | 6.26% | +123.3% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $29,334,000 | -2.7% | 1,630,591 | -4.1% | 5.01% | +29.9% |
| IMMU | Buy | IMMUNOMEDICS INC | $27,191,000 | +3.2% | 2,017,103 | +62.0% | 4.64% | +37.8% |
| ATRC | Sell | ATRICURE INC | $25,220,000 | -30.3% | 750,818 | -32.5% | 4.30% | -6.9% |
| CDNA | New | CAREDX INC | $23,702,000 | – | 1,085,752 | +100.0% | 4.05% | – |
| PFNX | New | PFENEX INC | $20,636,000 | – | 2,339,671 | +100.0% | 3.52% | – |
| MODN | Sell | MODEL N INC | $20,565,000 | -70.1% | 925,921 | -52.8% | 3.51% | -60.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $18,416,000 | +15.0% | 286,191 | +6.6% | 3.14% | +53.7% |
| VAPO | Sell | VAPOTHERM INC | $17,514,000 | +25.6% | 930,092 | -18.9% | 2.99% | +67.7% |
| XENT | Buy | INTERSECT ENT INC | $17,227,000 | -42.3% | 1,453,729 | +21.2% | 2.94% | -22.9% |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $17,080,000 | +752.3% | 7,580 | 0.0% | 2.92% | +1039.1% | |
| NEO | Sell | NEOGENOMICS INC | $16,860,000 | -56.9% | 610,664 | -54.3% | 2.88% | -42.4% |
| CDXS | Buy | CODEXIS INC | $16,590,000 | -12.5% | 1,486,598 | +25.3% | 2.83% | +16.8% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $16,552,000 | +2.0% | 1,843,246 | +11.3% | 2.83% | +36.2% |
| INSM | Sell | INSMED INC | $16,346,000 | -47.1% | 1,019,737 | -21.2% | 2.79% | -29.3% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $15,890,000 | – | 530,805 | +100.0% | 2.71% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $15,222,000 | +104.3% | 342,603 | +96.4% | 2.60% | +173.0% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $12,186,000 | – | 128,509 | +100.0% | 2.08% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $11,012,000 | +287.3% | 122,645 | +366.6% | 1.88% | +417.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $9,260,000 | -37.1% | 195,850 | -19.6% | 1.58% | -16.0% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,886,000 | +3.5% | 105,157 | +3.6% | 1.52% | +38.3% |
| HRTX | Sell | HERON THERAPEUTICS INC | $8,117,000 | -68.1% | 691,400 | -36.1% | 1.39% | -57.3% |
| SIBN | Sell | SI-BONE INC | $8,111,000 | -44.9% | 678,773 | -0.9% | 1.38% | -26.4% |
| TRHC | Sell | TABULA RASA HEALTHCARE INC | $6,999,000 | -31.4% | 133,858 | -36.2% | 1.20% | -8.4% |
| MYOK | Sell | MYOKARDIA INC | $5,630,000 | -85.5% | 120,095 | -77.4% | 0.96% | -80.6% |
| VCYT | Sell | VERACYTE INC | $5,439,000 | -52.4% | 223,722 | -45.3% | 0.93% | -36.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,432,000 | -6.4% | 22,828 | -13.9% | 0.93% | +24.9% |
| QDEL | Sell | QUIDEL CORP | $5,234,000 | +28.9% | 53,512 | -1.2% | 0.89% | +72.1% |
| ZYME | New | ZYMEWORKS INC | $5,140,000 | – | 144,909 | +100.0% | 0.88% | – |
| TECH | Sell | BIO TECHNE CORP | $4,808,000 | -22.1% | 25,356 | -9.8% | 0.82% | +4.1% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $4,766,000 | -16.5% | 120,234 | -1.1% | 0.81% | +11.5% |
| SLP | Sell | SIMULATIONS PLUS INC | $4,306,000 | +18.9% | 123,303 | -1.1% | 0.74% | +58.7% |
| BLUE | Buy | BLUEBIRD BIO INC | $4,230,000 | -25.4% | 92,047 | +42.5% | 0.72% | -0.3% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $3,920,000 | -53.5% | 93,329 | -49.7% | 0.67% | -37.9% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $3,262,000 | -28.1% | 44,859 | +3.2% | 0.56% | -4.0% |
| AMRN | Buy | AMARIN CORPORATION | $3,032,000 | -69.1% | 757,906 | +65.4% | 0.52% | -58.8% |
| EPZM | Sell | EPIZYME INC | $3,027,000 | -37.6% | 195,160 | -1.1% | 0.52% | -16.6% |
| GKOS | New | GLAUKOS CORPORATION | $2,795,000 | – | 90,565 | +100.0% | 0.48% | – |
| ADVM | New | ADVERIUM BIOTECHNOLOGIES INC | $2,367,000 | – | 242,300 | +100.0% | 0.40% | – |
| LHCG | Sell | LHC GROUP INC | $2,018,000 | -72.5% | 14,393 | -73.0% | 0.34% | -63.3% |
| IBB | Sell | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $1,801,000 | -29.7% | 16,713 | -21.3% | 0.31% | -6.1% |
| PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $1,787,000 | -20.0% | 17,285 | 0.0% | 0.30% | +6.6% | |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,616,000 | -13.0% | 18,241 | 0.0% | 0.28% | +16.5% | |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,199,000 | -31.4% | 48,129 | -1.1% | 0.20% | -8.5% |
| ITMR | New | ITAMAR MEDICAL LTD | $960,000 | – | 81,500 | +100.0% | 0.16% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS INC | $577,000 | -48.2% | 11,300 | -19.3% | 0.10% | -31.0% |
| GWPH | New | GW PHARMACEUTICALS PLC | $560,000 | – | 6,400 | +100.0% | 0.10% | – |
| CNC | New | CENTENE CORPORATION | $530,000 | – | 8,917 | +100.0% | 0.09% | – |
| DYNT | Buy | DYNATRONICS CORP | $389,000 | +270.5% | 450,000 | +257.0% | 0.07% | +407.7% |
| AGN | ALLERGAN PLC SHS | $382,000 | -7.3% | 2,157 | 0.0% | 0.06% | +22.6% | |
| MRK | MERCK & CO INC | $327,000 | -15.3% | 4,247 | 0.0% | 0.06% | +14.3% | |
| ABBV | ABBVIE | $313,000 | -14.0% | 4,114 | 0.0% | 0.05% | +12.8% | |
| SNY | SANOFI-SYNTHELABO | $291,000 | -12.9% | 6,650 | 0.0% | 0.05% | +16.3% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $291,000 | -13.1% | 3,535 | 0.0% | 0.05% | +16.3% | |
| HCAT | HEALTH CATALYST INC | $290,000 | -24.7% | 11,100 | 0.0% | 0.05% | +2.0% | |
| JNJ | JOHNSON AND JOHNSON | $283,000 | -10.2% | 2,161 | 0.0% | 0.05% | +20.0% | |
| PFE | PFIZER INC | $276,000 | -16.9% | 8,469 | 0.0% | 0.05% | +11.9% | |
| BAX | BAXTER INTERNATIONAL INC | $265,000 | -2.6% | 3,258 | 0.0% | 0.04% | +28.6% | |
| AMGN | AMGEN INC | $221,000 | -16.0% | 1,092 | 0.0% | 0.04% | +11.8% | |
| LABD | New | DIREXION DAILY S&P BIOTECH BEAR 3X SHARES | $217,000 | – | 15,401 | +100.0% | 0.04% | – |
| HRC | HILL-ROM HOLDINGS INC | $213,000 | -11.6% | 2,121 | 0.0% | 0.04% | +16.1% | |
| GRFS | GRIFOLS SA SPONSORED ADR CLASS B | $205,000 | -13.5% | 10,166 | 0.0% | 0.04% | +16.7% | |
| BIO | Exit | BIO RAD LABS INC | $0 | – | -548 | -100.0% | -0.03% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -692 | -100.0% | -0.03% | – |
| SNN | Exit | SMITH & NEPHEW PLC SPONSORED ADR | $0 | – | -4,472 | -100.0% | -0.03% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -2,548 | -100.0% | -0.03% | – |
| ANTM | Exit | ANTHEM INC COM | $0 | – | -795 | -100.0% | -0.03% | – |
| STE | Exit | STERIS CORP | $0 | – | -1,649 | -100.0% | -0.03% | – |
| TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -27,000 | -100.0% | -0.07% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -10,200 | -100.0% | -0.08% | – |
| TLGT | Exit | TELIGENT INC | $0 | – | -1,671,496 | -100.0% | -0.09% | – |
| ELGXQ | Exit | ENDOLOGIX INC | $0 | – | -2,885,081 | -100.0% | -0.58% | – |
| CSII | Exit | CARDIOVASCULAR SYSTEMS INC | $0 | – | -105,438 | -100.0% | -0.66% | – |
| TRUP | Exit | TRUPANION INC | $0 | – | -192,099 | -100.0% | -0.92% | – |
| MYL | Exit | MYLAN N V | $0 | – | -532,783 | -100.0% | -1.37% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -333,855 | -100.0% | -1.47% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -1,008,957 | -100.0% | -3.08% | – |
| OMCL | Exit | OMNICELL INC | $0 | – | -453,504 | -100.0% | -4.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 43 | Q2 2024 | 9.7% |
| NEOGENOMICS INC | 43 | Q2 2024 | 10.6% |
| SANOFI-SYNTHELABO | 41 | Q4 2023 | 1.9% |
| JOHNSON & JOHNSON | 41 | Q4 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q4 2023 | 1.6% |
| NOVARTIS AG-SPONSORED ADR | 34 | Q4 2023 | 0.4% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| MODEL N INC | 32 | Q1 2024 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OptimizeRx Corp | June 10, 2024 | 1,829,074 | 10.0% |
| TELA Bio, Inc.Sold out | June 10, 2024 | 0 | 0.0% |
| Societal CDMO, Inc. | April 09, 2024 | ? | ? |
| KORU Medical Systems, Inc. | February 14, 2024 | 5,158,444 | 11.3% |
| Performant Financial Corp | February 14, 2024 | 9,696,781 | 12.6% |
| PLIANT THERAPEUTICS, INC. | February 14, 2024 | 3,634,510 | 6.1% |
| SI-BONE, Inc. | February 14, 2024 | 2,532,227 | 6.2% |
| Sonendo, Inc. | February 14, 2024 | 5,446,491 | 10.0% |
| Miromatrix Medical Inc. | December 07, 2023 | 2,592,022 | 9.4% |
| Orthofix Medical Inc.Sold out | October 30, 2023 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-09 |
| SC 13G/A | 2024-07-10 |
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.